
Immucor
Provider of transfusion and transplantation diagnostic products.
- Healthcare
- biotechnology
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
* | $2.0b Valuation: $2.0b | Acquisition | |
Total Funding | 000k |
EUR | 2015 | 2016 |
---|---|---|
Revenues | 0000 | 0000 |
EBITDA | 0000 | 0000 |
Profit | 0000 | 0000 |
EV | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
Immucor is a prominent player in the transfusion and transplantation diagnostics market. The company specializes in providing diagnostic products that ensure the safe and accurate matching of blood and organs for patients in need. Immucor serves a diverse clientele, including hospitals, clinical laboratories, reference laboratories, and donor centers globally. The business model revolves around selling diagnostic kits and software solutions that streamline and automate the testing process, making it faster and more reliable. Revenue is generated through the sale of these products and ongoing support services. Immucor's commitment to innovation and quality has made it a trusted partner in the healthcare industry, dedicated to enhancing patient care and safety.
Keywords: transfusion, transplantation, diagnostics, blood matching, organ matching, hospitals, clinical laboratories, donor centers, automation, patient care.
Tech stack
Investments by Immucor
Edit